Microbe-binding Antibodies in the Female Genital Tract: Associations with the Vaginal Microbiome and Genital Immunology
The Journal of Immunology · 2024
DOI: 10.4049/jimmunol.2400233 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Immunology, 2024. Verfasst von Rachel Liu und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, University of Toronto, Toronto, Ontario, Canada. Hauptthemen laut MEDLINE: Vagina, Microbiota, Immunoglobulin A, Vaginosis, Bacterial. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 45 Literaturangaben. Gefördert von: Canadian Government | Canadian Institutes of Health Research (CIHR), Foreign, Commonwealth and Development Office (FCDO).
Abstract (Originalsprache)
Bacteria–Ig interactions maintain homeostasis in the gut through the clearance of pathogenic bacteria and the development of immune tolerance to inflammatory bacteria; whether similar interactions modulate inflammation and bacterial colonization in the female genital tract is uncertain. In this study, we used a flow cytometry–based assay to quantify microbe-binding IgA and IgG in the cervicovaginal secretions of 200 HIV-uninfected women from Nairobi, Kenya that were enriched for bacterial vaginosis. Total IgA and IgG were abundant and frequently demonstrated ex vivo binding to the key vaginal bacteria species Gardnerella vaginalis, Prevotella bivia, Lactobacillus iners, and Lactobacillus crispatus, which are largely microbe-specific. Microbe-binding Abs were generally not associated with the presence or abundance of their corresponding bacteria. Total and microbe-binding IgA and IgG were inversely correlated with total bacterial abundance and positively correlated with several proinflammatory cytokines (IL-6, TNF) and chemotactic chemokines (IP-10, MIG, MIP-1α, MIP-1β, MIP-3α, MCP-1, IL-8), independent of total bacterial abundance. Flow cytometry–based quantification of microbe-binding Abs provides a platform to investigate host–microbiota interactions in the female genital tract of human observational and interventional studies. In contrast to the gut, cervicovaginal microbe-binding IgA and IgG do not appear to be immunoregulatory but may indirectly mitigate bacteria-induced inflammation by reducing total bacterial abundance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
- Department of Immunology, University of Toronto, Toronto, Ontario, Canada.
- Partners for Health and Development in Africa, UNITID, College of Health Sciences, Nairobi, Kenya.
- Department of Global Health and Development, London School of Hygiene and Tropical Medicine, London, United Kingdom.
- Toronto General Hospital Research Institute, University Health Network, Toronto, Ontario, Canada.
ORCID-Profile: Rachel Liu, James Pollock, Suji Udayakumar, Joshua Kimani, Bryan Coburn, Rupert Kaul
Förderung
- Canadian Government | Canadian Institutes of Health Research (CIHR)
- Foreign, Commonwealth and Development Office (FCDO)
Zitieren
APA
Liu, R., Pollock, J., Huibner, S., Udayakumar, S., Irungu, E., Ngurukiri, P., Muthoga, P., Adhiambo, W., Kimani, J., Beattie, T., Coburn, B., & Kaul, R. (2024). Microbe-binding Antibodies in the Female Genital Tract: Associations with the Vaginal Microbiome and Genital Immunology. The Journal of Immunology. https://doi.org/10.4049/jimmunol.2400233
Vancouver
Liu R, Pollock J, Huibner S, Udayakumar S, Irungu E, Ngurukiri P, et al. Microbe-binding Antibodies in the Female Genital Tract: Associations with the Vaginal Microbiome and Genital Immunology. The Journal of Immunology. 2024. doi:10.4049/jimmunol.2400233
BibTeX
@article{Liu2024,
author = {Liu, Rachel and Pollock, James and Huibner, Sanja and Udayakumar, Suji and Irungu, Erastus and Ngurukiri, Pauline and Muthoga, Peter and Adhiambo, Wendy and Kimani, Joshua and Beattie, Tara and Coburn, Bryan and Kaul, Rupert},
title = {Microbe-binding Antibodies in the Female Genital Tract: Associations with the Vaginal Microbiome and Genital Immunology},
journal = {The Journal of Immunology},
year = {2024},
doi = {10.4049/jimmunol.2400233}
}
EUVIMED